WIGGINS MARK C (Chief Business Officer) purchased 7.9% of their position (1K shares) of TRACON PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $10.6K — a moderate purchase. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 12/30/2020ACC: 0001209191-20-065424
Officer· Chief Business Officer
Since Jan 2020
+1K
Net shares
Net buyer
$10.6K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
1K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+997.00
Price / share
$10.57
Trade value
$10.54K
% of position
7.9%
12/29/2020
12.70K→13.70K
Common Stock
Direct
Shares
+3.00
Price / share
$10.56
Trade value
$31.68
% of position
0.0%
12/29/2020
13.70K→13.70K
Total
Net shares
+1K
Net value
$10.57K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/29/2020 | P · Purchase | +997.00 | $10.57 | $10.54K | 7.9% | 12.70K | 13.70K |
| Common Stock Direct | 12/29/2020 | P · Purchase | +3.00 | $10.56 | $31.68 | 0.0% | 13.70K | 13.70K |
| Total | +1K | $10.57K | ||||||
Derivative Transactions0
No derivative transactions reported